HAIR LOSS​

  • Sep. 2022
  • Supported by
  • La Roche-Posay

CASE REPORT: REDUCTION OF THE TOPICAL MINOXIDIL INTOLERANCE SIGNS THROUGH THE INCLUSION OF A DERMOCOSMETIC HAIR CARE ROUTINE IMPROVING THE SCALP MICRO INFLAMMATION.​

For many years, topical minoxidil solution has proven to be an effective treatment for androgenetic alopecia​ ( However, some patients present scalp intolerance signs such as itching, scaling, exacerbation of​ seborrheic dermatitis and hair fiber drying which can affect the treatment adherence​ The association of topical minoxidil with a dermocosmetic hair care routine which contains active ingredientswith anti inflammatory and vascular action, such as Aminexil ® and Niacinamide, could help to reduce the scalp intolerance Additionally, active ingredients intended to restore softness, strength and shine of the hair​ fiber could improve the adherence to AGA treatment​ Therefore, the main objective was to evaluate the effectiveness of the dermocosmetic hair care routine toimprove the scalp intolerance signs, hair fiber quality and increase the treatment adherence to the topical minoxidil solution in subjects with long standing refractory severe androgenetic alopecia​

​ ​ BRAZIL